Aptevo Therapeutics Cash from Investing (TTM) Insights

Aptevo Therapeutics Inc (APVO)

0.71 +0.03 (+4.41%) USD | NASDAQ | Apr 26, 15:26

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	0.00
September 30, 2023	0.00
June 30, 2023	-0.004M
March 31, 2023	-0.029M
December 31, 2022	-0.029M
September 30, 2022	-0.147M
June 30, 2022	-0.156M
March 31, 2022	-0.522M
December 31, 2021	-0.713M
September 30, 2021	-0.683M
June 30, 2021	-0.67M
March 31, 2021	-0.279M
December 31, 2020	28.03M
September 30, 2020	28.12M
June 30, 2020	32.37M
March 31, 2020	32.37M
December 31, 2019	4.097M

Date	Value
September 30, 2019	13.14M
June 30, 2019	36.84M
March 31, 2019	49.13M
December 31, 2018	72.80M
September 30, 2018	9.915M
June 30, 2018	47.32M
March 31, 2018	55.80M
December 31, 2017	29.46M
September 30, 2017	87.64M
June 30, 2017	-27.48M
March 31, 2017	-49.15M
December 31, 2016	-47.39M
September 30, 2016	-52.25M
June 30, 2016	-2.932M
March 31, 2016	-2.457M
December 31, 2015	-1.527M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-0.713M

Minimum

Dec 2021

36.84M

Maximum

Jun 2019

9.038M

Average

-0.004M

Median

Jun 2023

Cash from Investing (TTM) Benchmarks